Initially elevated osteoprotegerin serum levels may predict a perioperative myocardial lesion in patients undergoing coronary artery bypass grafting

OBJECTIVE:We investigated whether osteoprotegerin (OPG), an important regulator in the genesis of arteriosclerosis and bone formation, is able to identify patients at risk for perioperative myocardial infarction measured as cardiac troponin I (cTNI) and signs of myocardial ischemia in the electrocar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 2006-01, Vol.34 (1), p.76-80
Hauptverfasser: Hermann-Arnhof, K M, Kästenbauer, T, Publig, T, Novotny, P, Loho, N, Schwarz, S, Köller, U, Fitzgerald, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 80
container_issue 1
container_start_page 76
container_title Critical care medicine
container_volume 34
creator Hermann-Arnhof, K M
Kästenbauer, T
Publig, T
Novotny, P
Loho, N
Schwarz, S
Köller, U
Fitzgerald, R
description OBJECTIVE:We investigated whether osteoprotegerin (OPG), an important regulator in the genesis of arteriosclerosis and bone formation, is able to identify patients at risk for perioperative myocardial infarction measured as cardiac troponin I (cTNI) and signs of myocardial ischemia in the electrocardiogram after coronary artery bypass grafting (CABG). DESIGN:Observational study. SETTING:Post-surgical intensive care unit of a tertiary care center. PATIENTS:Ninety-seven patients undergoing elective CABG. INTERVENTIONS:None. MEASUREMENT AND MAIN RESULTS:OPG and cTNI were measured before and 24 hrs after CABG. Additionally, cTNI was measured after 12 hrs. Electrocardiography was done before and immediately after CABG. OPG before CABG (OPGpre) measurements correlated with cTNI measurements after 12 hrs (cTNI12) (r = 0.56; p < .0001) and with cTNI measurements after 24 hrs (cTNI24) (r = 0.77; p < .0001). OPGpre measurements correlated with electrocardiographic findings after surgery (r = 0.65; p < .0001). There was a positive correlation between OPGpre value and the number of bypasses (r = 0.95; p < .0001). A strong correlation was found between OPGpre and homocysteine (r = 0.96; p < .0001). The median OPG presurgical level for the four patients with cardiac complications was found to be notably elevated (28.1 [26.6/31.0] pmol/L) in comparison with that for patients without complications (10.2 [3.7/16.9] pmol/L). CONCLUSIONS:OPG appears to be a useful marker for estimating risk for perioperative myocardial infarction in patients undergoing CABG, as demonstrated by signs of ischemia on electrocardiography.
doi_str_mv 10.1097/01.CCM.0000190429.52746.33
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67587955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67587955</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3921-bddb39588995d06f05d3afa6e327315fe0f7e1068a323d1f82215308d3f6c9dd3</originalsourceid><addsrcrecordid>eNpFkVGP1CAQxxuj8dbTr2CIib51BabQ4pvZnHrJGV_0mbBl2KvSUoHepd_DDyx7u8nywIT8fzPDzL-q3jG6ZVS1Hynb7nbft7QcpmjD1VbwtpFbgGfVhgmgNeUKnlcbShWtoVFwVb1K6XfBG9HCy-qKSWgbJtSm-nc7DXkw3q8EPT6YjJaElDHMMWQ8YBwmkjAuIykq-kRGs5I5oh36TAyZCxDKZfLwgGRcQ2-iLeUKnYYwkZI9Fw2nnMgyWYyHMEwH0ocYJhNXYmLGEvbrbFIih2hcLvrr6oUzPuGbc7yufn25-bn7Vt_9-Hq7-3xX96A4q_fW7kGJrlNKWCodFRaMMxKBt8CEQ-paZFR2BjhY5jrOj9vpLDjZK2vhuvpwqluG_btgynocUo_emwnDkrRsRdcqIQr46QT2MaQU0ek5DmMZQDOqj55oynTxRF880U-eaICS_PbcZdmPaC-pZxMK8P4MmNQb76KZ-iFduBaUVE1XuObEPQZf1pb--OURo75H4_P9U2vgjaw5pZKy8qqPn2HwH5vIqRI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67587955</pqid></control><display><type>article</type><title>Initially elevated osteoprotegerin serum levels may predict a perioperative myocardial lesion in patients undergoing coronary artery bypass grafting</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Hermann-Arnhof, K M ; Kästenbauer, T ; Publig, T ; Novotny, P ; Loho, N ; Schwarz, S ; Köller, U ; Fitzgerald, R</creator><creatorcontrib>Hermann-Arnhof, K M ; Kästenbauer, T ; Publig, T ; Novotny, P ; Loho, N ; Schwarz, S ; Köller, U ; Fitzgerald, R</creatorcontrib><description>OBJECTIVE:We investigated whether osteoprotegerin (OPG), an important regulator in the genesis of arteriosclerosis and bone formation, is able to identify patients at risk for perioperative myocardial infarction measured as cardiac troponin I (cTNI) and signs of myocardial ischemia in the electrocardiogram after coronary artery bypass grafting (CABG). DESIGN:Observational study. SETTING:Post-surgical intensive care unit of a tertiary care center. PATIENTS:Ninety-seven patients undergoing elective CABG. INTERVENTIONS:None. MEASUREMENT AND MAIN RESULTS:OPG and cTNI were measured before and 24 hrs after CABG. Additionally, cTNI was measured after 12 hrs. Electrocardiography was done before and immediately after CABG. OPG before CABG (OPGpre) measurements correlated with cTNI measurements after 12 hrs (cTNI12) (r = 0.56; p &lt; .0001) and with cTNI measurements after 24 hrs (cTNI24) (r = 0.77; p &lt; .0001). OPGpre measurements correlated with electrocardiographic findings after surgery (r = 0.65; p &lt; .0001). There was a positive correlation between OPGpre value and the number of bypasses (r = 0.95; p &lt; .0001). A strong correlation was found between OPGpre and homocysteine (r = 0.96; p &lt; .0001). The median OPG presurgical level for the four patients with cardiac complications was found to be notably elevated (28.1 [26.6/31.0] pmol/L) in comparison with that for patients without complications (10.2 [3.7/16.9] pmol/L). CONCLUSIONS:OPG appears to be a useful marker for estimating risk for perioperative myocardial infarction in patients undergoing CABG, as demonstrated by signs of ischemia on electrocardiography.</description><identifier>ISSN: 0090-3493</identifier><identifier>EISSN: 1530-0293</identifier><identifier>DOI: 10.1097/01.CCM.0000190429.52746.33</identifier><identifier>PMID: 16374159</identifier><identifier>CODEN: CCMDC7</identifier><language>eng</language><publisher>Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</publisher><subject>Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Biomarkers - blood ; Cardiology. Vascular system ; Cohort Studies ; Confidence Intervals ; Coronary Artery Bypass - adverse effects ; Coronary Artery Bypass - methods ; Coronary Disease - diagnostic imaging ; Coronary Disease - surgery ; Coronary heart disease ; Female ; Glycoproteins - blood ; Glycoproteins - metabolism ; Graft Rejection ; Graft Survival ; Heart ; Humans ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Osteoprotegerin ; Perioperative Care - methods ; Postoperative Complications - blood ; Postoperative Complications - diagnosis ; Predictive Value of Tests ; Probability ; Prognosis ; Radiography ; Receptors, Cytoplasmic and Nuclear - blood ; Receptors, Cytoplasmic and Nuclear - metabolism ; Receptors, Tumor Necrosis Factor - blood ; Receptors, Tumor Necrosis Factor - metabolism ; Risk Assessment ; Sensitivity and Specificity ; Severity of Illness Index ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Treatment Outcome</subject><ispartof>Critical care medicine, 2006-01, Vol.34 (1), p.76-80</ispartof><rights>2006 by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3921-bddb39588995d06f05d3afa6e327315fe0f7e1068a323d1f82215308d3f6c9dd3</citedby><cites>FETCH-LOGICAL-c3921-bddb39588995d06f05d3afa6e327315fe0f7e1068a323d1f82215308d3f6c9dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17396948$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16374159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hermann-Arnhof, K M</creatorcontrib><creatorcontrib>Kästenbauer, T</creatorcontrib><creatorcontrib>Publig, T</creatorcontrib><creatorcontrib>Novotny, P</creatorcontrib><creatorcontrib>Loho, N</creatorcontrib><creatorcontrib>Schwarz, S</creatorcontrib><creatorcontrib>Köller, U</creatorcontrib><creatorcontrib>Fitzgerald, R</creatorcontrib><title>Initially elevated osteoprotegerin serum levels may predict a perioperative myocardial lesion in patients undergoing coronary artery bypass grafting</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description>OBJECTIVE:We investigated whether osteoprotegerin (OPG), an important regulator in the genesis of arteriosclerosis and bone formation, is able to identify patients at risk for perioperative myocardial infarction measured as cardiac troponin I (cTNI) and signs of myocardial ischemia in the electrocardiogram after coronary artery bypass grafting (CABG). DESIGN:Observational study. SETTING:Post-surgical intensive care unit of a tertiary care center. PATIENTS:Ninety-seven patients undergoing elective CABG. INTERVENTIONS:None. MEASUREMENT AND MAIN RESULTS:OPG and cTNI were measured before and 24 hrs after CABG. Additionally, cTNI was measured after 12 hrs. Electrocardiography was done before and immediately after CABG. OPG before CABG (OPGpre) measurements correlated with cTNI measurements after 12 hrs (cTNI12) (r = 0.56; p &lt; .0001) and with cTNI measurements after 24 hrs (cTNI24) (r = 0.77; p &lt; .0001). OPGpre measurements correlated with electrocardiographic findings after surgery (r = 0.65; p &lt; .0001). There was a positive correlation between OPGpre value and the number of bypasses (r = 0.95; p &lt; .0001). A strong correlation was found between OPGpre and homocysteine (r = 0.96; p &lt; .0001). The median OPG presurgical level for the four patients with cardiac complications was found to be notably elevated (28.1 [26.6/31.0] pmol/L) in comparison with that for patients without complications (10.2 [3.7/16.9] pmol/L). CONCLUSIONS:OPG appears to be a useful marker for estimating risk for perioperative myocardial infarction in patients undergoing CABG, as demonstrated by signs of ischemia on electrocardiography.</description><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Cardiology. Vascular system</subject><subject>Cohort Studies</subject><subject>Confidence Intervals</subject><subject>Coronary Artery Bypass - adverse effects</subject><subject>Coronary Artery Bypass - methods</subject><subject>Coronary Disease - diagnostic imaging</subject><subject>Coronary Disease - surgery</subject><subject>Coronary heart disease</subject><subject>Female</subject><subject>Glycoproteins - blood</subject><subject>Glycoproteins - metabolism</subject><subject>Graft Rejection</subject><subject>Graft Survival</subject><subject>Heart</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Osteoprotegerin</subject><subject>Perioperative Care - methods</subject><subject>Postoperative Complications - blood</subject><subject>Postoperative Complications - diagnosis</subject><subject>Predictive Value of Tests</subject><subject>Probability</subject><subject>Prognosis</subject><subject>Radiography</subject><subject>Receptors, Cytoplasmic and Nuclear - blood</subject><subject>Receptors, Cytoplasmic and Nuclear - metabolism</subject><subject>Receptors, Tumor Necrosis Factor - blood</subject><subject>Receptors, Tumor Necrosis Factor - metabolism</subject><subject>Risk Assessment</subject><subject>Sensitivity and Specificity</subject><subject>Severity of Illness Index</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Treatment Outcome</subject><issn>0090-3493</issn><issn>1530-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkVGP1CAQxxuj8dbTr2CIib51BabQ4pvZnHrJGV_0mbBl2KvSUoHepd_DDyx7u8nywIT8fzPDzL-q3jG6ZVS1Hynb7nbft7QcpmjD1VbwtpFbgGfVhgmgNeUKnlcbShWtoVFwVb1K6XfBG9HCy-qKSWgbJtSm-nc7DXkw3q8EPT6YjJaElDHMMWQ8YBwmkjAuIykq-kRGs5I5oh36TAyZCxDKZfLwgGRcQ2-iLeUKnYYwkZI9Fw2nnMgyWYyHMEwH0ocYJhNXYmLGEvbrbFIih2hcLvrr6oUzPuGbc7yufn25-bn7Vt_9-Hq7-3xX96A4q_fW7kGJrlNKWCodFRaMMxKBt8CEQ-paZFR2BjhY5jrOj9vpLDjZK2vhuvpwqluG_btgynocUo_emwnDkrRsRdcqIQr46QT2MaQU0ek5DmMZQDOqj55oynTxRF880U-eaICS_PbcZdmPaC-pZxMK8P4MmNQb76KZ-iFduBaUVE1XuObEPQZf1pb--OURo75H4_P9U2vgjaw5pZKy8qqPn2HwH5vIqRI</recordid><startdate>200601</startdate><enddate>200601</enddate><creator>Hermann-Arnhof, K M</creator><creator>Kästenbauer, T</creator><creator>Publig, T</creator><creator>Novotny, P</creator><creator>Loho, N</creator><creator>Schwarz, S</creator><creator>Köller, U</creator><creator>Fitzgerald, R</creator><general>by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200601</creationdate><title>Initially elevated osteoprotegerin serum levels may predict a perioperative myocardial lesion in patients undergoing coronary artery bypass grafting</title><author>Hermann-Arnhof, K M ; Kästenbauer, T ; Publig, T ; Novotny, P ; Loho, N ; Schwarz, S ; Köller, U ; Fitzgerald, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3921-bddb39588995d06f05d3afa6e327315fe0f7e1068a323d1f82215308d3f6c9dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Cardiology. Vascular system</topic><topic>Cohort Studies</topic><topic>Confidence Intervals</topic><topic>Coronary Artery Bypass - adverse effects</topic><topic>Coronary Artery Bypass - methods</topic><topic>Coronary Disease - diagnostic imaging</topic><topic>Coronary Disease - surgery</topic><topic>Coronary heart disease</topic><topic>Female</topic><topic>Glycoproteins - blood</topic><topic>Glycoproteins - metabolism</topic><topic>Graft Rejection</topic><topic>Graft Survival</topic><topic>Heart</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Osteoprotegerin</topic><topic>Perioperative Care - methods</topic><topic>Postoperative Complications - blood</topic><topic>Postoperative Complications - diagnosis</topic><topic>Predictive Value of Tests</topic><topic>Probability</topic><topic>Prognosis</topic><topic>Radiography</topic><topic>Receptors, Cytoplasmic and Nuclear - blood</topic><topic>Receptors, Cytoplasmic and Nuclear - metabolism</topic><topic>Receptors, Tumor Necrosis Factor - blood</topic><topic>Receptors, Tumor Necrosis Factor - metabolism</topic><topic>Risk Assessment</topic><topic>Sensitivity and Specificity</topic><topic>Severity of Illness Index</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hermann-Arnhof, K M</creatorcontrib><creatorcontrib>Kästenbauer, T</creatorcontrib><creatorcontrib>Publig, T</creatorcontrib><creatorcontrib>Novotny, P</creatorcontrib><creatorcontrib>Loho, N</creatorcontrib><creatorcontrib>Schwarz, S</creatorcontrib><creatorcontrib>Köller, U</creatorcontrib><creatorcontrib>Fitzgerald, R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hermann-Arnhof, K M</au><au>Kästenbauer, T</au><au>Publig, T</au><au>Novotny, P</au><au>Loho, N</au><au>Schwarz, S</au><au>Köller, U</au><au>Fitzgerald, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Initially elevated osteoprotegerin serum levels may predict a perioperative myocardial lesion in patients undergoing coronary artery bypass grafting</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>2006-01</date><risdate>2006</risdate><volume>34</volume><issue>1</issue><spage>76</spage><epage>80</epage><pages>76-80</pages><issn>0090-3493</issn><eissn>1530-0293</eissn><coden>CCMDC7</coden><abstract>OBJECTIVE:We investigated whether osteoprotegerin (OPG), an important regulator in the genesis of arteriosclerosis and bone formation, is able to identify patients at risk for perioperative myocardial infarction measured as cardiac troponin I (cTNI) and signs of myocardial ischemia in the electrocardiogram after coronary artery bypass grafting (CABG). DESIGN:Observational study. SETTING:Post-surgical intensive care unit of a tertiary care center. PATIENTS:Ninety-seven patients undergoing elective CABG. INTERVENTIONS:None. MEASUREMENT AND MAIN RESULTS:OPG and cTNI were measured before and 24 hrs after CABG. Additionally, cTNI was measured after 12 hrs. Electrocardiography was done before and immediately after CABG. OPG before CABG (OPGpre) measurements correlated with cTNI measurements after 12 hrs (cTNI12) (r = 0.56; p &lt; .0001) and with cTNI measurements after 24 hrs (cTNI24) (r = 0.77; p &lt; .0001). OPGpre measurements correlated with electrocardiographic findings after surgery (r = 0.65; p &lt; .0001). There was a positive correlation between OPGpre value and the number of bypasses (r = 0.95; p &lt; .0001). A strong correlation was found between OPGpre and homocysteine (r = 0.96; p &lt; .0001). The median OPG presurgical level for the four patients with cardiac complications was found to be notably elevated (28.1 [26.6/31.0] pmol/L) in comparison with that for patients without complications (10.2 [3.7/16.9] pmol/L). CONCLUSIONS:OPG appears to be a useful marker for estimating risk for perioperative myocardial infarction in patients undergoing CABG, as demonstrated by signs of ischemia on electrocardiography.</abstract><cop>Hagerstown, MD</cop><pub>by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</pub><pmid>16374159</pmid><doi>10.1097/01.CCM.0000190429.52746.33</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-3493
ispartof Critical care medicine, 2006-01, Vol.34 (1), p.76-80
issn 0090-3493
1530-0293
language eng
recordid cdi_proquest_miscellaneous_67587955
source MEDLINE; Journals@Ovid Complete
subjects Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Biomarkers - blood
Cardiology. Vascular system
Cohort Studies
Confidence Intervals
Coronary Artery Bypass - adverse effects
Coronary Artery Bypass - methods
Coronary Disease - diagnostic imaging
Coronary Disease - surgery
Coronary heart disease
Female
Glycoproteins - blood
Glycoproteins - metabolism
Graft Rejection
Graft Survival
Heart
Humans
Intensive care medicine
Male
Medical sciences
Middle Aged
Osteoprotegerin
Perioperative Care - methods
Postoperative Complications - blood
Postoperative Complications - diagnosis
Predictive Value of Tests
Probability
Prognosis
Radiography
Receptors, Cytoplasmic and Nuclear - blood
Receptors, Cytoplasmic and Nuclear - metabolism
Receptors, Tumor Necrosis Factor - blood
Receptors, Tumor Necrosis Factor - metabolism
Risk Assessment
Sensitivity and Specificity
Severity of Illness Index
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
Treatment Outcome
title Initially elevated osteoprotegerin serum levels may predict a perioperative myocardial lesion in patients undergoing coronary artery bypass grafting
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T05%3A53%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Initially%20elevated%20osteoprotegerin%20serum%20levels%20may%20predict%20a%20perioperative%20myocardial%20lesion%20in%20patients%20undergoing%20coronary%20artery%20bypass%20grafting&rft.jtitle=Critical%20care%20medicine&rft.au=Hermann-Arnhof,%20K%20M&rft.date=2006-01&rft.volume=34&rft.issue=1&rft.spage=76&rft.epage=80&rft.pages=76-80&rft.issn=0090-3493&rft.eissn=1530-0293&rft.coden=CCMDC7&rft_id=info:doi/10.1097/01.CCM.0000190429.52746.33&rft_dat=%3Cproquest_cross%3E67587955%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67587955&rft_id=info:pmid/16374159&rfr_iscdi=true